Identiv, Inc.
For the period ended Dec 31, 2025. Filed Mar 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 26, 2026
INVE$2.66+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In thousands)
| Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net income (loss) | $(18,003) | $74,820 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Depreciation and amortization | 2,026 | 2,870 |
| Gain on sale of discontinued operations, net of taxes | — | (103,509) |
| Amortization of operating lease right-of-use assets | 424 | 1,473 |
| Write down of inventory | 639 | 807 |
| Amortization of debt issuance costs | — | 113 |
| Stock-based compensation expense | 3,202 | 8,730 |
| Impairment of operating lease right-of-use assets | 800 | — |
| Loss on disposal of property and equipment | — | 98 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | 150 | 6,158 |
| Inventories | (309) | 4,482 |
| Prepaid expenses and other assets | 2,857 | (2,613) |
| Accounts payable | 1,032 | (5,318) |
| Deferred revenue | 2,760 | 311 |
| Accrued income taxes payable | (885) | (2,017) |
| Accrued expenses and other liabilities | (131) | (365) |
| Operating lease liabilities | (1,265) | (1,473) |
| Net cash used in operating activities | (6,703) | (15,433) |
| Cash flows from investing activities: | ||
| Capital expenditures | (1,108) | (1,493) |
| Proceeds from sale of discontinued operations, net of cash sold | — | 142,986 |
| Proceeds from investment | 298 | — |
| Net cash provided by (used in) investing activities | (810) | 141,493 |
| Cash flows from financing activities: | ||
| Borrowings under revolving loan facility, net of issuance costs | — | 9,887 |
| Repayments under revolving loan facility | — | (20,000) |
| Taxes paid related to net share settlement of restricted stock units | (431) | (1,642) |
| Repurchases of common stock | — | (1,879) |
| Net cash used in financing activities | (431) | (13,634) |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | 907 | (864) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash | (7,037) | 111,562 |
| Cash, cash equivalents and restricted cash | ||
| Beginning of period | 135,946 | 24,384 |
| End of period | $128,909 | $135,946 |
| Supplemental Disclosures of Cash Flow Information: | ||
| Interest paid | $— | $324 |
| Income taxes payments (refunds), net | $(1,909) | $4,181 |
| Non-cash investing and financing activities: | ||
| Dividends earned on Series B preferred stock | $824 | $883 |
| Operating lease right-of-use assets obtained in exchange for operating lease liabilities | $65 | $560 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.